Resources
Valuable insights for building effective commercialization models
PHARMA IN JAPAN – CRITICAL AREAS OF TRANSFORMATION
eBook #1 in a series of 3 A SEISMIC SHIFT IN A GO-TO-MARKET STRATEGY Top pharma companies in Japan face three critical challenges to transformation, that when addressed increase the potential for success: 1.Access to and focus on the physician is not what it was. So...
Corporate and Investment Banking: An Agenda for Change
McKinsey Working Paper on CIB No 9 "The transformation, however, is a significant undertaking, not least because it demands changes in entrenched behaviors and habits."
BCG BNP Paribas Corporate Treasury Insights 2018
"The battle for treasurers’ hearts and minds is intensifying, and it is increasingly being waged over trust. "
SAM Prescription for Commercial Success: Eyeforpharma
Over the years the pharmaceutical sales strategy has evolved.SAM is the latest strategy under the microscope. In this article read how pharma has kept up with the new age of marketing through the role of SAM (Strategic Account Management).
Clarity Overview
A video overview of Clarity Engagement Solutions, Ltd. Watch a video overview of Clarity Engagement Solutions – the leading provider of consulting, training and coaching for life science and medical device field force teams.Source: Clarity Engagement Solutions
Future of Care Management – Eleven Insights
Hospitals and health systems need to focus on the future care management to reduce avoidable health care spending. Providers will assume a financial risk for health care utilization. This will be assumed at some stage if not imminent. Find out more about our 11...
Eyeforpharma: Key Account Management
Marie Crespo asks whether we’ve truly understood, and fully adopted a true key account management (KAM) strategy. Marie lays the basics of Key Account Management here.
Harvard Business Review Article: How to Solve the Cost Crisis in Health Care
We’re measuring the wrong things in Health Care the wrong way. The biggest problem with health care isn’t with insurance or politics.Source: Robert S. Kaplan and Michael E. Porter | Harvard Business Review